Key result
Elevated hsCRP was independently associated with higher odds of projected 5-year cardiovascular disease risk among adults with HIV on ART.
Why the study?
People living with HIV have a two-fold higher incidence of cardiovascular disease compared to HIV-negative persons, but predictors of cardiovascular disease risk among people living with HIV in Nigeria are still evolving.
Cross-Sectional (n=180)
No
Answers are grounded in this paper and cite their sources.
In adults living with HIV on antiretroviral therapy in northern Nigeria, most have low-to-moderate 5-year estimated cardiovascular disease risk, with elevated hsCRP (>3.03 mg/L), hypercholesterolemia, older age, and male sex serving as independent predictors of higher risk.
Background People living with HIV (PLWH) exhibit two-fold higher incidence of cardiovascular disease compared to HIV-negative persons. However, predictors of cardiovascular disease risk in PLWH are still evolving. The objective of this study is to evaluate the predictors of cardiovascular disease among PLWH in Nigeria. Methods This cross-sectional study was conducted among adult patients attending a large HIV clinic in Kano, northern Nigeria. We used systematic sampling to recruit participants and computed their 5-year projected CVD risk using the Data collection on Adverse effects of Anti-HIV Drugs (DAD) equation. Results The majority of participants were female (70.6%). The estimated median 5-year CVD risk was 0.7% (interquartile range, IQR 0.4, 10). The majority of participants (58.9%) had a low risk of developing cardiovascular disease, while 28.9% had a moderate risk. Cardiovascular disease was associated with elevated high-sensitivity C-reactive protein (hsCRP) > 3.03 mg/L [adjusted odds ratio, aOR: 4.58, 95% CI: 2.09–10.04), p = 0.001], increasing age [aOR 2.38, 95% CI (1.48–4.50), p = 0.020], male sex [aOR 2.16, 95% CI (1.03–4.53), p = 0.040] and hypercholesterolemia [aOR 3.03, 95% CI (1.68–4.86), p = 0.005]. Conclusion The majority of PLWH in our setting have low to moderate risk of developing cardiovascular disease. Cardiovascular disease risk was associated with elevated hsCRP, increasing age, male sex, and hypercholesterolemia. Our findings highlight the importance of early CVD risk stratification to prevent morbidity and mortality among PLWH.
No takes yet. Share an insight, caveat, or question.
Abdulkadir et al. (2026) conducted a cross-sectional in HIV infection on antiretroviral therapy (n=180). Elevated high-sensitivity C-reactive protein (hsCRP > 3.03 mg/L) vs. Lower hsCRP (≤ 3.03 mg/L) was evaluated on High 5-year projected cardiovascular disease risk (estimated using the DAD equation) (OR 4.58, 95% CI 2.09-10.05, p=<0.001). Elevated hsCRP was independently associated with higher odds of projected 5-year cardiovascular disease risk among adults with HIV on ART.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: